COMMUNIQUÉS West-GlobeNewswire

Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report
04/07/2019
ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report Amsterdam, The Netherlands – 3 July 2019 Esperite N.V. (Euronext: ESP, “ Esperite ”) announces that its statutory auditor, accon [...]
Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing
04/07/2019
Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing Patent broadly covers genetic biomarkers and biomarker combinations indicating antibiotic resistance First of eleven [...]
Führende österreichische Klinik, die Klinik Pirawarth, bietet eine medikamentenfreie Behandlung von Patienten mit Depressionen und Schmerzen mit Nexstim SmartFocus TMS an
04/07/2019
Pressemitteilung, Helsinki, 4. Juli 2019 um 9.00 (EET) Führende österreichische Klinik, die Klinik Pirawarth, bietet eine medikamentenfreie Behandlung von Patienten mit Depressionen und Schmerzen mit Nexstim SmartFocus [...]
Bone Therapeutics SA: Transparency notification received from Mr. J. Reymann
04/07/2019
Regulated information Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings Gosselies, Belgium, 4 July 2019, 7am CEST – BONE THERAPEUTICS ( Euronext Brussels and Paris: BOTHE), the [...]
Bone Therapeutics SA : Notification de transparence reçue de la part de M. J. Reymann
04/07/2019
Information réglementée Article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes Gosselies, Belgique, le 4 juillet 2019, 07h00 CEST – BONE THERAPEUTICS (code Euronext [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2019
BURLINGTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to ten new employees consisting of an aggregate of 29,050 stock options and 5,350 [...]
North Bud Farms Closes Second Tranche of Private Placement Financing
03/07/2019
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 03, 2019 (GLOBE NEWSWIRE) -- [...]
Aclaris Therapeutics Announces Appointment of Maxine Gowen to Board of Directors
03/07/2019
WAYNE, Pa., July 03, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced the [...]
Digirad Corporation Announces Execution of Merger Agreement to Acquire ATRM Holdings, Inc. to Launch Holding Company Structure
03/07/2019
Plans to Create Preferred Stock which is Intended to be Listed on Nasdaq Names David Noble as Permanent CFO SUWANEE, Ga., July 03, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or “DRAD”) [...]
Fluidigm Announces Conference Call and Webcast of Second Quarter 2019 Financial Results
03/07/2019
SOUTH SAN FRANCISCO, Calif., July 03, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced [...]
Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9th
03/07/2019
Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9 th Live webcast beginning at 8:30am EDT / 2:30pm CEST Saint-Herblain (France), July 3, 2019 – Valneva SE [...]
Le Dr. Stanley Plotkin, spécialiste mondial des vaccins, participera à la journée investisseurs consacrée à la R&D de Valneva le 9 juillet à New York
03/07/2019
Le Dr. Stanley Plotkin, spécialiste mondial des vaccins, participera à la journée investisseurs consacrée à la R&D de Valneva le 9 juillet à New York Conférence retransmise en direct à partir de 8h30 EDT / 14h30 [...]
Emerald Health Therapeutics Commends Government of Ontario for Expanding Retail Cannabis Store Licences in Canada’s Largest Province
03/07/2019
Emerald to expand product selection and sales potential in Ontario adult-use market VANCOUVER, British Columbia, July 03, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or “the Company”) (TSXV: [...]
Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019
03/07/2019
-- Of the Votes Received to Date, More than 99% Are Voting in Favor of the Merger Proposal -- More Votes Are Needed to Reach 50% of the Outstanding Shares to Go Forward with the Special Meeting -- Every Vote Is [...]
DRAFT RESOLUTIONS of Extraordinary General Meeting of Shareholders of joint stock company “Grindeks” to be held on 17 July 2019
03/07/2019
Referring to the previously announced that the mandatory share repurchase offer will not affect Board’s view in paying dividends and the overall development of the “Grindeks” Group currently indicates its ability to [...]
INmune Bio Co-Founder and CEO Presents at Maxim Group’s Conference on Alzheimer’s Disease
03/07/2019
LA JOLLA, Calif., July 03, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced [...]
Philips ships two-millionth AED, helping to save lives across the globe
03/07/2019
July 3, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced shipment of its two-millionth AED (Automated External Defibrillator), which was [...]
OrthoPediatrics Corp. to Sponsor 26th Annual International Meeting on Advanced Spine Techniques (IMAST)
03/07/2019
WARSAW, Ind., July 03, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it will continue [...]
Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain
03/07/2019
Hamilton, Bermuda, July 03, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]

Pages